A promising tumor dormancy therapy using a 14-membered macrolide for patients with unresectable non-small cell lung cancer: Basic and clinical analysis

Journal of Nara Medical Association

Volumn 51, Issue 5, 2000, Pages 304-320

  Majima, T ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Clarithromycin (CAM); Cytokine; Metastasis; Non small cell lung cancer; Tumor dormancy therapy

Indexed keywords

CLARITHROMYCIN; CYTOKINE; GAMMA INTERFERON; INTEGRIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; MACROLIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CYTOKINE PRODUCTION; LEWIS CARCINOMA; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PROGNOSIS; QUALITY OF LIFE;

EID: 0034535719     PISSN: 13450069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Enhanced interleukin production after long-term administration of erythromycin stearate
2. Suppression of virulence factors of pseudomonas aeruginosa by erythromycin
3. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation
4. Evaluation of the immunostimulating activity of erythromycin in man
5. Antitumor effect of erythromycin in mice
6. Significant survival benefit to patients with advanced non-small cell lung cancer from treatment with clarithromycin
7. Chemotherapy vs supportive care in advanced non-small cell lung cancer
8. Polychemotherapy in advanced non-small cell lung cancer
9. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
10. Biochemical interactions of tumor cells with the basement membrane
11. Cancer cell invasion and metastasis
12. Integrins: Versatility, modulation, signaling in cell adhesion
13. VLA proteins in the integrin family: Structures, functions and their role on leukocytes
14. In vitro and in vivo consequences of VL A-2 expression on rhabdomiosarcoma cells
15. Induction of experimental bone metastasis in mice by transfection of integrin α 4 β 1 into tumor cells
16. VCAM-1 on activated endothelium interacts with the leukocytes integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site
17. Structure of the integrin VLA-4 and its cell-cell and cell matrix adhesion functions
18. Regulated expression and binding three VLA (bata-1) integrin receptors on T cells
19. Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression
20. Analysis of integrin receptors for laminin and type IV collagen on metastatic B 16 melanoma cells
21. Laminin receptor on platelets is the integrin VLA-6
22. Transforming growth factor and cancer
23. Production of multiple growth factor by human non-small cell lung carcinoma cell line
24. The expression of the platelet-derived and transforming growth factor genes in human non-small cell lung cancer cell lines is related to tumor stroma formation in nude mice tumor
25. Comparison of normal and tumorigenic endothelial cells: Differences in thrombospondin production and responses to transforming growth factor-beta
26. Transforming growth factor β 1-induced changes in cell migration, proliferation and angiogenesis in the chicken cholioallntoic membrane
27. Anti-Transforming growth factor (TGF)-β antibodies inhibit breast cancer celltumorigenicity and increase mouse spleen natural killer cell activity
28. Potentiation of metastatic capacity by transforming growth factor-β 1 gene transfection
29. Transforming growth factor - β (TGF - β)- mediated immunosuppression in the tumor bearing state: Enhanced production of TGF-β and a progressive increase in TGF-β susceptibility of antitumor CD 4+T cell function
30. A highly immunogenic tumor transfected with a murine transforming growth factor type β 1 cDNA escapes immune surveillance
31. 4+T cell activity
32. Regulatory Mechanisms for production of IFN-gamma and TNF by antitumor T cell or macrophages in the tumor bearing state
33. Antitumor and antimetastatic activity of Interleukin 12 against Murine tumors
34. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production
35. Evidence for the involvement of interleukin 6 in experimental cancer cachexia
36. Mechanisms of experimental cancer cachexia. Interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to IL-6-mediated cancer cachexia
37. Identity of tumor necrosis factor and the macrophage-secreted factor cachectin
38. Interleukin 10(IL-10) inhibits human lymphocyte interferon gamma production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells